Using the CDAHFD diet-based model, where animals develop fatty livers with fibrosis, IL-22-ScFv reduced NAS scores and hepatic fibrosis, accompanied by decline in gene expression of key fibrosis genes. The gene discussed is IL22; the disease is Hepatic fibrosis.